Steinhart Richard I 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Steinhart Richard I（CIK 1293789）在 3 家公司共报告 16 笔 SEC Form 4 内部人交易（最近一笔 2026-09-04）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-04 | Actinium Pharmaceuticals, Inc. (ATNM) | 董事 | 买入 | 62,800 | $0 |
| 2026-06-17 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 35 | $0 |
| 2026-05-22 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 17,500 | $0 |
| 2026-05-22 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 卖出 | 6,845 | $7,461 |
| 2026-05-14 | ATOSSA THERAPEUTICS, INC. (ATOS) | 董事 | 买入 | 10,000 | $0 |
| 2026-05-07 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 9,000 | $0 |
| 2026-03-16 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 33 | $0 |
| 2026-03-16 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 35 | $0 |
| 2025-12-15 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 33 | $0 |
| 2025-12-15 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 35 | $0 |
| 2025-09-16 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 33 | $0 |
| 2025-09-16 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 35 | $0 |
| 2025-07-22 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 4,375 | $0 |
| 2025-07-22 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 625 | $0 |
| 2025-06-16 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 33 | $0 |
| 2025-06-16 | BioXcel Therapeutics, Inc. (BTAI) | Chief Financial Officer | 买入 | 35 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04